The Effect of Xiaoxinbi Fang （消心痹方） Combined with Western Medicine on Chinese Medicine Symptoms and Left Ventricular Function in Patients with Hypertrophic Cardiomyopathy

ZHANG Dawei; DAI Mei; ZHOU Xusheng; HAN Yao; HUA Chunxuan; ZHU Fuyong; ZHANG Zhuhua

doi:10.13288/j.11-2166/r.2016.15.013

您当前的位置：

首页 >

文章列表页 >

The Effect of Xiaoxinbi Fang （消心痹方） Combined with Western Medicine on Chinese Medicine Symptoms and Left Ventricular Function in Patients with Hypertrophic Cardiomyopathy

更新时间：2021-11-17

- The Effect of Xiaoxinbi Fang （消心痹方） Combined with Western Medicine on Chinese Medicine Symptoms and Left Ventricular Function in Patients with Hypertrophic Cardiomyopathy
- Journal of Traditional Chinese Medicine Vol. 57, Issue 15, Pages: 1313-1316(2016)
- 作者机构：
  
  首都医科大学附属北京中医医院
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2016.15.013
  CLC： R542.2
- Published：2016
- 稿件说明：
移动端阅览
[1]张大炜,戴梅,周旭升,韩垚,华春萱,褚福永,张竹华.消心痹方联合西药对肥厚型心肌病患者中医症状及左室功能的影响[J].中医杂志,2016,57(15):1313-1316.

ZHANG Dawei, DAI Mei, ZHOU Xusheng, et al. The Effect of Xiaoxinbi Fang （消心痹方） Combined with Western Medicine on Chinese Medicine Symptoms and Left Ventricular Function in Patients with Hypertrophic Cardiomyopathy[J]. Journal of Traditional Chinese Medicine2016, 57(15): 1313-1316.
[1]张大炜,戴梅,周旭升,韩垚,华春萱,褚福永,张竹华.消心痹方联合西药对肥厚型心肌病患者中医症状及左室功能的影响[J].中医杂志,2016,57(15):1313-1316. DOI： 10.13288/j.11-2166/r.2016.15.013.

ZHANG Dawei, DAI Mei, ZHOU Xusheng, et al. The Effect of Xiaoxinbi Fang （消心痹方） Combined with Western Medicine on Chinese Medicine Symptoms and Left Ventricular Function in Patients with Hypertrophic Cardiomyopathy[J]. Journal of Traditional Chinese Medicine2016, 57(15): 1313-1316. DOI： 10.13288/j.11-2166/r.2016.15.013.

摘要

目的观察消心痹方联合西药对肥厚型心肌病（HCM）的中医症状及对左室功能的影响。方法67例经彩色多普勒超声心动图证实的HCM患者随机分为对照组33例和治疗组34例。对照组给予倍他乐克缓释片47.5 mg口服

每日1次

根据血压、心率调整剂量治疗。治疗组在对照组治疗的基础上给予消心痹方口服

每日1剂。两组疗程均为90天。观察两组患者胸闷、胸痛、心悸、乏力、气短、头晕中医症状疗效

超声心动图检测两组患者治疗前后室间隔厚度（IVS）、左室后壁厚度（IVPW）及二者比值（IVS/IVPW）变化

检测两组治疗前后血浆NT-pro BNP并比较NYHA分级水平变化情况。结果治疗组治疗后胸痛、心悸、乏力、气短症状总有效率显著优于对照组（P<0.05）。两组治疗后NT-pro BNP含量均较本组治疗前明显降低（P<0.01）;治疗组治疗后IVS、IVPW及IVS/LVPW均较治疗前显著降低（P<0.05）;治疗组治疗后NT-pro BNP含量及IVS、IVPW、IVS/LVPW均明显低于对照组（P<0.05）。两组治疗后NYHA心功能分级均明显降低

且治疗组优于对照组（P<0.05）。结论消心痹方联合西药可以改善HCM患者临床症状

提高左室功能。

Abstract

Objective To observe the effect of Xiaoxinbi Fang（消心痹方） combined with western medicine on Chinese medicine symptoms and left ventricular function of hypertrophic cardiomyopathy（ HCM）. Methods Randomly divided 67 cases of patients with HCM proved by Color Doppler Echocardiography into a control group with 33 cases and a treatment group with 34 cases. The control group was given Betaloc sustained release tablets（47. 5 mg orally

once per day） and adjusted the dose according to blood pressure and heart rates. The treatment group was given Xiaoxinbi Fang in addition to the treatment of the control group

one dose per day. The treatment courses were both for 90 days. Observed curative effects of Chinese medicine symptoms

including chest distress

chest pain

heart palpitations

fatigue

shortness of breath and dizziness. Using echocardiography to examine the variation of interventricular septal thickness（ IVS）

left ventricular posterior wall thickness（ IVPW） and their ratio（ IVS / IVPW） before and after treatment. Examined NT-pro BNP content in plasma and compared the change of NYHA ranking level of both groups before and after treatment. Results The total effective rates of chest pain

heart palpitations

fatigue

shortness of breath of the treatment group after treatment was remarkably superior to those of the control group（ P <0. 05）. The levels of NT-pro BNP in the two groups after treatment were both remarkably lower than those before treatment（ P < 0. 01）; IVS

IVPW and IVS / LVPW in the treatment group after treatment remarkably decreased compared with those before treatment（ P < 0. 05）; NT-pro BNP levels of the treatment group after treatment as well as IVS

IVPW and IVS / LVPW were all lower than those of the control group（ P < 0. 05）. NYHA cardiac functional grading in the two groups after treatment both remarkably decreased

with the treatment group superior to the control group（ P < 0. 05）. Conclusion Xiaoxinbi Fang combined with western medicine can improve clinical symptoms of patients with HCM and improve left ventricular function.

关键词

Keywords

references

查看原文

Views

114

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Differentiation and Treatment of Non-Obstructive Hypertrophic Cardiomyopathy Based on the Concept of Nourishing the Heart and Softening the Hardness

LI Qinghai′s Experience on Treatment of Hypertrophic Cardiomyopathy

Construction and Application of a Real-World Cohort of Community-Acquired Pneumonia Based on a Multimodal Large-Scale Traditional Chinese Medicine Big Data Platform

Efficacy and Economic Evaluation of Weishi Qingjin Formula （苇石清金方）in the Treatment of Adult Community-Acquired Pneumonia with Phlegm-Heat Obstructing the Lung Syndrome：A Multicenter Retrospective Real-World Cohort Study

Research on the Correlation Between "Tiangui （天癸）" and Female Reproductive Genetic Diseases

Related Author

GENG Xiaofei

FAN Xinbiao

SUN Xitong

SHANG Wenyu

LI Wenxiu

ZHANG Chi

ZHANG Junping

高帅飞

Related Institution

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine/National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion

The Third Affiliated Hospital of Henan University of Traditional Chinese Medicine

河南中医药大学第三附属医院

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰